IL1B and chronic obstructive pulmonary disease: The second technique used the IL-1β cutoff point at 130 pg/mL, which was identified as the best classifier to distinguish overlap cluster 2 from clusters 1 or 3 in the test study and was used alongside subject disease status (asthma or COPD).